pentoxifylline has been researched along with Alcohol Drinking in 5 studies
Alcohol Drinking: Behaviors associated with the ingesting of ALCOHOLIC BEVERAGES, including social drinking.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of the clinical effectiveness and cost-effectiveness of STeroids Or Pentoxifylline for Alcoholic Hepatitis trial was to resolve the clinical dilemma on the use of prednisolone or PTX." | 9.20 | The clinical effectiveness and cost-effectiveness of STeroids Or Pentoxifylline for Alcoholic Hepatitis (STOPAH): a 2 × 2 factorial randomised controlled trial. ( Allison, M; Austin, A; Bowers, M; Day, C; Downs, N; Forrest, E; Gleeson, D; Homer, T; Kirkman, S; Masson, S; McCune, A; Mellor, J; O'Grady, J; Patch, D; Ratcliffe, I; Richardson, P; Roderick, P; Ryder, S; Stanton, L; Ternent, L; Thursz, M; Vale, L; Wright, M, 2015) |
| "The aim of the clinical effectiveness and cost-effectiveness of STeroids Or Pentoxifylline for Alcoholic Hepatitis trial was to resolve the clinical dilemma on the use of prednisolone or PTX." | 5.20 | The clinical effectiveness and cost-effectiveness of STeroids Or Pentoxifylline for Alcoholic Hepatitis (STOPAH): a 2 × 2 factorial randomised controlled trial. ( Allison, M; Austin, A; Bowers, M; Day, C; Downs, N; Forrest, E; Gleeson, D; Homer, T; Kirkman, S; Masson, S; McCune, A; Mellor, J; O'Grady, J; Patch, D; Ratcliffe, I; Richardson, P; Roderick, P; Ryder, S; Stanton, L; Ternent, L; Thursz, M; Vale, L; Wright, M, 2015) |
| "Although short-term outcome in severe alcoholic hepatitis (SAH) is well described, its long-term course remains uncharacterised." | 1.39 | Determinants of long-term outcome in severe alcoholic hepatitis. ( Goubet, S; Heneghan, MA; Potts, JR; Verma, S, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Potts, JR | 1 |
| Goubet, S | 1 |
| Heneghan, MA | 1 |
| Verma, S | 1 |
| Thursz, M | 1 |
| Forrest, E | 1 |
| Roderick, P | 1 |
| Day, C | 1 |
| Austin, A | 1 |
| O'Grady, J | 1 |
| Ryder, S | 1 |
| Allison, M | 1 |
| Gleeson, D | 1 |
| McCune, A | 1 |
| Patch, D | 1 |
| Wright, M | 1 |
| Masson, S | 1 |
| Richardson, P | 1 |
| Vale, L | 1 |
| Mellor, J | 1 |
| Stanton, L | 1 |
| Bowers, M | 1 |
| Ratcliffe, I | 1 |
| Downs, N | 1 |
| Kirkman, S | 1 |
| Homer, T | 1 |
| Ternent, L | 1 |
| Amini, M | 1 |
| Runyon, BA | 1 |
| Mathurin, P | 1 |
| Lucey, MR | 1 |
| McCarty, MF | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effect of Omega-5 Fatty Acid Supplement on Markers of Inflammation and Oxidative Stress in Patients With Severe Alcoholic Hepatitis Treated With Prednisone[NCT03732586] | 40 participants (Actual) | Interventional | 2018-09-30 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for pentoxifylline and Alcohol Drinking
| Article | Year |
|---|---|
Alcoholic hepatitis 2010: a clinician's guide to diagnosis and therapy.
Topics: Alcohol Deterrents; Alcohol Drinking; Anti-Inflammatory Agents; Baclofen; Combined Modality Therapy; | 2010 |
Management of alcoholic hepatitis.
Topics: Acetylcysteine; Adrenal Cortex Hormones; Alcohol Drinking; Enteral Nutrition; Free Radical Scavenger | 2012 |
1 trial available for pentoxifylline and Alcohol Drinking
| Article | Year |
|---|---|
The clinical effectiveness and cost-effectiveness of STeroids Or Pentoxifylline for Alcoholic Hepatitis (STOPAH): a 2 × 2 factorial randomised controlled trial.
Topics: Adult; Aged; Alcohol Drinking; Cost-Benefit Analysis; Double-Blind Method; Female; Glucocorticoids; | 2015 |
2 other studies available for pentoxifylline and Alcohol Drinking
| Article | Year |
|---|---|
Determinants of long-term outcome in severe alcoholic hepatitis.
Topics: Adult; Aged; Alcohol Drinking; Drug Therapy, Combination; Female; Glucocorticoids; Hepatitis, Alcoho | 2013 |
Interleukin-6 as a central mediator of cardiovascular risk associated with chronic inflammation, smoking, diabetes, and visceral obesity: down-regulation with essential fatty acids, ethanol and pentoxifylline.
Topics: Alcohol Drinking; Animals; Cardiovascular Diseases; Diabetes Mellitus; Fatty Acids, Essential; Human | 1999 |